Aachen (ots) - Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD). Tegacorat, a non-steroidal Selective Glucocorticoid ...
Aachen (ots) - - The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. - In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. - A Phase II trial will commence later this year. Grünenthal announced today that the ...
LTS Lohmann Therapie-Systeme AG
Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS’ Lakewood, New Jersey facility. The new offering focuses initially on product ...
VITUS Privatklinik Prof. Dr. Stehling GmbH
OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 patients treated between 2017 and 2024. The report is the largest dataset to date on this treatment. Radical prostatectomy ...
Cologne (ots) - FIBO 2026, the world’s leading trade show for fitness, wellness, and health, marks a strategic shift in the industry toward data-driven health and longevity models. Where traditional strength training once dominated, digital applications, connected systems, and AI-powered analytics are now shaping market development. FIBO is positioning itself as an international platform and catalyst for a new ...
Suresnes, France (ots/PRNewswire) - - Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. - Growth over the financial year was driven by increased sales in oncology, particularly in the United States. - Several partnership agreements in oncology and neurology strengthen the Group's R&D portfolio in rare diseases. - Achieving 2025 ...
Sharjah Government Media Bureau
SHARJAH, UAE (ots) - The Emirate of Sharjah, UAE, has reached a new global milestone by obtaining "Advanced Affiliate" membership in the World Health Organization’s (WHO) Global Network for Age-Friendly Cities and Communities. This makes Sharjah the first Arab city to achieve this prestigious status. This achievement underscores the emirate's deep commitment to enhancing the well-being of its senior residents and ...
Gütersloh (ots) - Most people these days look online for answers to questions on health. However, many have doubts on the integrity and quality of the information provided by social media platforms and AI chatbots. The Bertelsmann Stiftung would like to contribute to promoting reliable sources and increasing confidence in digital information on health by means of its ...
IEVA (Independent European Vape Alliance)
Brussels (ots) - As the 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) approaches (17–22 November 2025, Geneva), the Independent European Vape Alliance (IEVA) calls on the World Health Organization (WHO) and its member states to finally place harm reduction at the centre of the global tobacco control debate. IEVA ...
Athens, Greece (ots/PRNewswire) - After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through ...
Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...
Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...
Bremervörde (Germany) (ots) - From autonomous driving to advanced safety technologies – the innovations presented at the IAA Mobility captivate car enthusiasts. However, one key comfort factor is often overlooked: the car seat. To meet the demand for ergonomic design, the production has become increasinglycomplex – up to 12 percent of a car’s development costs are attributable to the seat. “But not every seat ...
Baar, Switzerland (ots/PRNewswire) - Mikrona Group AG, a leading Swiss provider of solutions for orthodontics and digital dentistry, has acquired FTC Frey Trading & Consulting Sàrl and its affiliated training platform, MYDENTALEXPERT Sàrl. Mikrona Group is part of Healthcare Holding Schweiz AG, which is managed by Winterberg Advisory and KKA Partners. Healthcare Holding Schweiz AG, through its subsidiary Mikrona Group AG, has completed the acquisition of FTC Frey Trading & ...
Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...
ABDA Bundesvgg. Dt. Apothekerverbände
Berlin (ots) - ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the pharmaceutical and healthcare sectors in Germany and beyond. It shows that the number of pharmacies has decreased again. At the ...
Paris (ots/PRNewswire) - After two years of co-development marked by close collaboration, Groupement Hospitalier Loos Haubourdin (GHLH) has renewed its trust in Intalio, a recognized leader in digital transformation for organizations, by officially adopting the Intalio Assure solution, the digital version of the ...
Hagleitner Hygiene International GmbH
IEVA (Independent European Vape Alliance)
Brussels (ots) - In the lead-up to World No Tobacco Day 2025 on 31 May, the Independent European Vape Alliance (IEVA) highlights compelling evidence that the majority of e-cigarette users in Europe are former smokers. This underscores the important role that vaping can play in tobacco harm reduction and as a tool to ...
Bundesinnung der Hörakustiker KdöR
London (ots/PRNewswire) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare ...
Bosch Healthcare Solutions GmbH
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
